Acute febrile myelodysplasia and pneumonitis due to human herpesvirus 6 after accelerated chemotherapy [2]

American Journal of Medicine

Volumn 111, Issue 4, 2001, Pages 329-330

  Safdar, Amar ^a   Brown, Arthur E ^a   Malkin, Mark ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; CEFTAZIDIME; DEXAMETHASONE; FOSCARNET; PROCARBAZINE; VANCOMYCIN;

ASTROCYTOMA; BLOOD CULTURE; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CLINICAL FEATURE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; LABORATORY TEST; LETTER; MYELODYSPLASIA; PHYSICAL EXAMINATION; PNEUMONIA; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS REACTIVATION;

EID: 0034827475     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00858-0     Document Type: Article

References (10)

1. Human herpesvirus 6: The virus and the search for its role as a human pathogen
2. Detection of antibodies to human herpesvirus-6 using immunofluorescence assay
3. A prospective study of human herpesvirus-6 infection in renal transplantation
4. Disseminated active HHV-6 infections in patients with AIDS
5. Human herpes-virus-6-infection in bone marrow transplantation
6. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation
7. Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of US infants
8. Human herpesvirus six (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients
9. Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus 6
10. Puzzles concerning the pathogenicity of human herpesvirus 6